Estrogen and progesterone receptor content of endometrial carcinomas: Comparison of total tissue versus cancer component analysis
- 1 March 1990
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 36 (3) , 363-368
- https://doi.org/10.1016/0090-8258(90)90143-9
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Purification of T47D Human Progesterone Receptor and Immunochemical Characterization with Monoclonal AntibodiesMolecular Endocrinology, 1988
- Localization of Progesterone Receptor with Monoclonal Antibodies to the Human Progestin Receptor*Endocrinology, 1988
- Endometrial adenocarcinoma estrogen receptor content: Association of clinicopathologic features with immunohistochemical analysis compared with standard biochemical methodsAmerican Journal of Obstetrics and Gynecology, 1987
- Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinomaAmerican Journal of Obstetrics and Gynecology, 1985
- 8 Oestrogen and progesterone receptors: Physiological and pathological considerationsClinics in Endocrinology and Metabolism, 1983
- Monoclonal antibodies as probes for estrogen receptor detection and characterizationThe Journal of Steroid Biochemistry and Molecular Biology, 1982
- Quality control in steroid hormone receptor assaysCancer, 1980
- Monoclonal antibodies to human estrogen receptor.Proceedings of the National Academy of Sciences, 1980
- Monoclonal antibodies to estrophilin: probes for the study of estrogen receptors.Proceedings of the National Academy of Sciences, 1980
- CORRELATION OF ESTROGEN AND PROGESTERONE RECEPTORS WITH HISTOLOGIC DIFFERENTIATION IN ENDOMETRIAL ADENOCARCINOMA1979